Hisashi Narahara

No ORCID on file · 64 papers in corpus
review 2009
Histology and histopathology ·doi:10.14670/hh-24.1181

Endometriosis, a disease affecting 3-10% of women of reproductive age, is characterized by the ectopic growth of endometrial tissue. Increasingly, endometriosis is also becoming recognized as a condition in which ectopic endometrial cells e…

lab-animal 2009
Fertility and sterility ·doi:10.1016/j.fertnstert.2009.06.055

Simvastatin significantly inhibited the proliferation of endometriotic stromal cells, attenuated the collagen gel contraction mediated by these cells, and suppressed endometriotic stromal cell attachment to collagen fibers. Simvastatin is c…

review 2008
Clinical medicine. Pathology ·doi:10.4137/cpath.s487

Tamoxifen is widely used for endocrine treatment and breast cancer prevention. It acts as both an estrogen antagonist in breast tissue and an estrogen agonist in the female lower genital tract. Tamoxifen causes severe gynecologic side effec…

lab-animal 2007
Human Reproduction ·doi:10.1093/humrep/del485

BACKGROUND: Excessive fibrosis is frequently associated with endometriosis. To evaluate the involvement of the extracellular matrix contractility of endometriotic stromal cells (ECSCs) in the pathogenesis of endometriosis-associated fibrosi…

review 2007
·doi:10.2174/1573404810703020113

Endometriosis, a disease affecting 3-10% of women of reproductive age, is characterized by the ectopic growth of endometrial tissue. Increasingly, endometriosis is also becoming recognized as a condition in which ectopic endometrial cells e…

lab-animal 2006
American journal of physiology. Endocrinology and metabolism ·doi:10.1152/ajpendo.00135.2006

Most of the current medical treatments for endometriosis aim to downregulate estrogen activity. However, a high recurrence rate after medical treatment has been the most significant problem. BAY 11-7085, a soluble inhibitor of NK-kappaB act…

lab-animal 2006
Human Reproduction ·doi:10.1093/humrep/del270

BACKGROUND: Most of the current medical treatments for endometriosis aim to down-regulate the estrogen activity. However, a high recurrence rate after medical treatments has been the most significant problem. Beta-hydroxyisovalerylshikonin …

lab-animal 2006
Fertility and sterility ·doi:10.1016/j.fertnstert.2005.10.023

OBJECTIVE: To evaluate the effect of hypoxia on the production of vascular endothelial growth factor (VEGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) in the human fallopian tube. DESIGN: The secretion of VEGF and sFlt-1 by cultured o…

lab-animal 2006
Journal of the Society for Gynecologic Investigation ·doi:10.1016/j.jsgi.2006.03.007

OBJECTIVE: The aim of the current study is to evaluate the effect of insulin-like growth factor-I (IGF-I) on the production of vascular endothelial growth factor (VEGF) in the human fallopian tube. METHODS: Human oviductal epithelial cells…

lab-animal 2006
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/08916930600929487

The aim of the present study was to evaluate the effects of interleukin (IL)-1beta on the production of vascular endothelial growth factor (VEGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) in the human fallopian tube. Human oviductal e…

lab-animal 2005
Molecular human reproduction ·doi:10.1093/molehr/gah249

Most of the current medical treatments for endometriosis aim to down-regulate the estrogen activity. However, a high recurrence rate after medical treatments has been the most significant problem. Bufalin is a major digoxin-like immunoreact…

lab-animal 2004
Fertility and sterility ·doi:10.1016/j.fertnstert.2004.03.029

Interferon (IFN)-beta, not IFN-alpha, suppresses vascular endothelial growth factor secretion in endometriotic cyst stromal cells. It was suggested that IFN-beta may be more suitable than IFN-alpha as an anti-endometriotic agent.

lab-animal 2004
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2004-0354

To evaluate the involvement of chemokines in the pathogenesis of endometriosis, we investigated the expression of CXC chemokines in cultured ovarian endometriotic cyst stromal cells (ECSC), endometrial stromal cells with endometriosis (ESCw…

lab-animal 2000
European Journal of Obstetrics & Gynecology and Reproductive Biology ·doi:10.1016/s0301-2115(00)00293-1

OBJECTIVE: We visualized and investigated the intracellular calcium waves propagated by platelet-activating factor (PAF) in cultured human myometrial cells. STUDY DESIGN: Myometrial cells were stimulated with PAF ranging between 10(-8) and…